药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Gallopamil
The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Linagliptin.
Tetracosactide
Fish oil
The risk or severity of hypoglycemia can be increased when Fish oil is combined with Linagliptin.
Tetracosactide
Caroverine
The risk or severity of hypoglycemia can be increased when Caroverine is combined with Linagliptin.
Tetracosactide
Penfluridol
The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Linagliptin.
Tetracosactide
Lidoflazine
The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Linagliptin.
Tetracosactide
Terodiline
The risk or severity of hypoglycemia can be increased when Terodiline is combined with Linagliptin.
Tetracosactide
Otilonium
The risk or severity of hypoglycemia can be increased when Otilonium is combined with Linagliptin.
Tetracosactide
Bencyclane
The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Linagliptin.
Tetracosactide
Vinpocetine
The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Linagliptin.
Tetracosactide
Tetrahydropalmatine
The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Linagliptin.
Tetracosactide
Naftopidil
The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Linagliptin.
Tetracosactide
Carboxyamidotriazole
The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Linagliptin.
Tetracosactide
Niludipine
The risk or severity of hypoglycemia can be increased when Niludipine is combined with Linagliptin.
Tetracosactide
Lacidipine
The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Linagliptin.
Tetracosactide
Darodipine
The risk or severity of hypoglycemia can be increased when Darodipine is combined with Linagliptin.
Tetracosactide
Cilnidipine
The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Linagliptin.
Tetracosactide
Azelnidipine
The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Linagliptin.
Tetracosactide
Aranidipine
The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Linagliptin.
Tetracosactide
Tolfenamic acid
The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Linagliptin.
Tetracosactide
Pinaverium
The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Linagliptin.